The manufacturer of Taxotere is being sued for failing to
warn patients treated with the chemotherapy
drug for permanent hair loss (alopecia).
What is Taxotere?
Taxotere is an injectable form of chemotherapy, used for the treatment of breast, lung, prostate, stomach and head/neck cancer. Taxotere has often been a preferred option by patients as the treatment is only needed every three weeks, rather than every week in similar chemotherapy treatments.
Manufacturers of Taxotere are being sued because they failed to warn doctors and patients in the United States of the risk of permanent hair loss (alopecia).